FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shelby Reed

Research Profile

Geographic Areas

United States

Activities & Behaviors

Concepts & Ideas

Procedures

Hospitalization

Disorders

Chemicals & Drugs

Antineoplastic Agents

Living Beings

Co-author Network

Publications

TOP 3
Yanhong Li; Matthew P Neilson; Kevin A Schulman; David J Whellan; Wayne C Levy; Shelby D Reed
Associations Between Seattle Heart Failure Model Scores and Health Utilities: Findings From HF-ACTION.
Shelby D Reed; Kevin A Schulman; Michaela A Dinan; Gary H Lyman
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.
Esi Morgan Dewitt; Henry A Glick; Jeffrey D Greenberg; Joel M Kremer; Yanhong Li; George Reed; Kevin J Anstrom; Jeffrey R Curtis; Kevin A Schulman; Shelby D Reed
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shelby Reed (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yanhong Li; Matthew P Neilson; Kevin A Schulman; David J Whellan; Wayne C Levy; Shelby D Reed
Associations Between Seattle Heart Failure Model Scores and Health Utilities: Findings From HF-ACTION.
Journal of cardiac failure 2013;19(5):311-6.
2013: Shelby D Reed; Kevin A Schulman; Michaela A Dinan; Gary H Lyman
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2013;15(3):203-11.
2013: Esi Morgan Dewitt; Henry A Glick; Jeffrey D Greenberg; Joel M Kremer; Yanhong Li; George Reed; Kevin J Anstrom; Jeffrey R Curtis; Kevin A Schulman; Shelby D Reed
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
The Journal of rheumatology 2013;40(2):127-36.
2013: Shital Kamble; Kevin A Schulman; Kevin P Weinfurt; Shelby D Reed
Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial.
Medical decision making : an international journal of the Society for Medical Decision Making 2013;33(2):215-24.
2013: Shelby D Reed
How country-specific should a country-specific cost-effectiveness analysis be?
European heart journal 2013;34(3):166-7.
2012: Shelby D Reed; Gary H Lyman
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.
Cancer 2012;118(24):6298-9; author reply 6299-300.
2012: S B Stewart; Charles D Scales; Judd W Moul; Shelby D Reed
Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
Prostate cancer and prostatic diseases 2012;15(4):380-5.
2012: Ana M Valverde; Shelby D Reed; Kevin A Schulman
Proposed 'grant-and-access' program with price caps could stimulate development of drugs for very rare diseases.
Health affairs (Project Hope) 2012;31(11):2528-35.
2012: Shelby D Reed; Gregory P Samsa; Kevin A Schulman; Mark E Dunlap; William E Kraus; Yanhong Li; Michael R Zile; David J Whellan
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
The American journal of cardiology 2012;110(8):1150-5.
2012: Shelby D Reed; Kevin A Schulman; Sunfa Cheng; Stephen J Ellis; John J Isitt; Yanhong Li; David J Whellan
Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION.
Journal of cardiac failure 2012;18(10):784-91.
2012: Ziad F Gellad; Ira M Jacobson; David Kershenobich; Michael P Manns; John G McHutchison; Andrew J Muir; Kimberly A Brown; Robert Flisiak; Kevin A Schulman; Ala I Sharara; William Sievert; Shelby D Reed
Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(6):876-86.
2012: Shital Kamble; Kevin A Schulman; Shelby D Reed
Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(5):632-8.
2012: Michaela A Dinan; W Robert Lee; Shelby D Reed; Timothy J Robinson; Charles D Scales; Lesley H Curtis; Timothy M Zagar; Kevin A Schulman
Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007.
International journal of radiation oncology, biology, physics 2012;82(5):e781-6.
2012: Esi Morgan Dewitt; Michaela A Dinan; Joëlle Y Friedman; Chelsea A Grussemeyer; Li Lin; Kevin A Schulman; Shelby D Reed
Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(2):277-83.
2012: Ziad F Gellad; Shelby D Reed; Andrew J Muir
Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Antiviral therapy 2012;17(6 Pt B):1189-99.
2012: Daniel L Riddle; Shelby D Reed; Dennis Ang; Matthew J Bair; Levent Dumenci; Khaled J; Mark P Jensen; Francis J Keefe; Kurt Kroenke
A phase III randomized three-arm trial of physical therapist delivered pain coping skills training for patients with total knee arthroplasty: the KASTPain protocol.
BMC musculoskeletal disorders 2012;13():149.
2012: Shelby D Reed; Gregory P Samsa; Kevin A Schulman; David Whellan; Margaret T Bowers; Felicia L Graham; Shital Kamble; Yanhong Li; Sara Paul; Daniel Polsky; Barbara J Riegel
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions.
Circulation. Cardiovascular quality and outcomes 2012;5(1):113-9.
2011: Shelby D Reed; Zubin J Eapen; Kevin A Schulman
End point selection in acute decompensated heart failure clinical trials: economic end points.
Heart failure clinics 2011;7(4):529-37.
2011: Zubin J Eapen; Shelby D Reed; Lesley H Curtis; Adrian F Hernandez; Eric D Peterson
Do heart failure disease management programs make financial sense under a bundled payment system?
American heart journal 2011;161(5):916-22.
2011: Shelby D Reed; Charles D Scales; Suzanne B Stewart; Jielin Sun; Judd W Moul; Kevin A Schulman; Jianfeng Xu
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer.
The Journal of urology 2011;185(3):841-7.
2010: Marco Barbieri; Michael Drummond; Frans Rutten; John Cook; Henry A Glick; Joanna Lis; Shelby D Reed; Mark Sculpher; Johan L Severens
What do international pharmacoeconomic guidelines say about economic data transferability?
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(8):1028-37.
2010: Chia-Hung Chou; Shelby D Reed; Jennifer S Allsbrook; Janet L Steele; Kevin A Schulman; Michael J Alexander
Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Neurosurgery 2010;67(2):345-51; discussion 351-2.
2010: Shelby D Reed; David Whellan; Yanhong Li; Joëlle Y Friedman; Stephen J Ellis; Ileana L Piña; Sharon J Settles; Linda Davidson-Ray; Johanna L Johnson; Lawton S Cooper; Christopher M O'Connor; Kevin A Schulman
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.
Circulation. Cardiovascular quality and outcomes 2010;3(4):374-81.
2010: Deverick J Anderson; Jean Marie Arduino; Shelby D Reed; Daniel J Sexton; Keith Steven Kaye; Chelsea A Grussemeyer; Senaka A Peter; Chantelle Hardy; Yong Il Choi; Joëlle Y Friedman; Vance G Fowler
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2010;31(7):701-9.
2010: Bryan T Vaughn; Steven R DeVrieze; Shelby D Reed; Kevin Schulman
Can we close the income and wealth gap between specialists and primary care physicians?
Health affairs (Project Hope) 2010;29(5):933-40.
2010: Shelby D Reed; Yanhong Li; Eugene Z Oddone; Alice M Neary; Melinda M Orr; Janet M Grubber; Felicia L Graham; Maren K Olsen; Laura P Svetkey; Rowena J Dolor; Benjamin J Powers; Martha B Adams; Hayden B Bosworth
Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension.
American journal of hypertension 2010;23(2):142-8.
2010: Cassandra Moran; Chelsea A Grussemeyer; James R Spalding; Daniel K Benjamin; Shelby D Reed
Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections.
American journal of infection control 2010;38(1):78-80.
2010: Shital Kamble; Marilyn J Telen; Michaela A Dinan; Chelsea A Grussemeyer; Shelby D Reed
Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.
American journal of hematology 2010;85(1):79-81.
2009: Mark E Patterson; William C Grant; Seth Glickman; Barry M Massie; Susan E Ammon; Paul W Armstrong; John G F Cleland; Joseph F Collins; Koon K Teo; Kevin Schulman; Shelby D Reed
Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation.
Journal of cardiac failure 2009;15(10):819-27.
2009: Hayden B Bosworth; Maren K Olsen; Janet M Grubber; Alice M Neary; Melinda M Orr; Benjamin J Powers; Martha B Adams; Laura P Svetkey; Shelby D Reed; Yanhong Li; Rowena J Dolor; Eugene Z Oddone
Two self-management interventions to improve hypertension control: a randomized trial.
Annals of internal medicine 2009;151(10):687-95.
2009: Michaela A Dinan; Chia-Hung Chou; Bradley G Hammill; Felicia L Graham; Kevin Schulman; Marilyn J Telen; Shelby D Reed
Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.
American journal of hematology 2009;84(11):703-9.
2009: Shelby D Reed; Diana S M Buist; Melissa L Anderson; Erin J Aiello Bowles; Edith Dawn Fitzgibbons; Deborah Seger; Katherine M Newton
Short-term (1-2 mo) hormone therapy cessation before mammography.
Menopause (New York, N.Y.) 2009;16(6):1125-31.
2009: Esi Morgan Dewitt; Li Lin; Henry A Glick; Kevin J Anstrom; Kevin Schulman; Shelby D Reed
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank.
Clinical therapeutics 2009;31(8):1871-80; discussion 1858.
2009: Shelby D Reed; Kevin A Schulman
Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(5):637-40.
2009: Michael Drummond; Marco Barbieri; John Cook; Henry A Glick; Joanna Lis; Farzana Malik; Shelby D Reed; Frans Rutten; Mark J Sculpher; Johan Severens
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(4):409-18.
2009: Shelby D Reed; Yanhong Li; Kevin J Anstrom; Kevin Schulman
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2185-91.
2009: Cassandra Moran; Chelsea A Grussemeyer; James R Spalding; Daniel K Benjamin; Shelby D Reed
Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.
The Pediatric infectious disease journal 2009;28(5):433-5.
2009: Shelby D Reed; Evette J Ludman; Katherine M Newton; Louis Grothaus; Andrea Z LaCroix; Larissa Nekhlyudov; Leslie Spangler; Luesa Jordan; Kelly Ehrlich; Terry Bush
Depressive symptoms and menopausal burden in the midlife.
Maturitas 2009;62(3):306-10.
2009: Yanhong Li; Joëlle Y Friedman; Betsy F O'Neal; Matthew J Hohenboken; ROBERT GRIFFITHS; Martin E Stryjewski; John P Middleton; Kevin Schulman; Jula K Inrig; Vance G Fowler; Shelby D Reed
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(2):428-34.
2008: Tomohiko Takahashi; Shelby D Reed; Kevin Schulman
Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease.
Nephrology (Carlton, Vic.) 2008;13(5):419-27.
2008: Shelby D Reed; Kevin J Anstrom; Damon M Seils; Robert M Califf; Kevin Schulman
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs.
Health affairs (Project Hope) 2008;27(5):w360-70.
2008: Kimberly H Allison; Elizabeth Tenpenny; Shelby D Reed; Elizabeth M Swisher; Rochelle L Garica
Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2008;16(4):329-43.
2008: Kimberly H Allison; Shelby D Reed; Lynda F Voigt; Carolyn D Jordan; Kathryn M Newton; Rochelle L Garcia
Diagnosing endometrial hyperplasia: why is it so difficult to agree?
The American journal of surgical pathology 2008;32(5):691-8.
2008: Leslie Spangler; Delia Scholes; Robert L Brunner; John Robbins; Shelby D Reed; Katherine M Newton; Jennifer L Melville; Andrea Z LaCroix
Depressive symptoms, bone loss, and fractures in postmenopausal women.
Journal of general internal medicine 2008;23(5):567-74.
2008: Christopher E Cox; Shelby D Reed; Joseph A Govert; Jo E Rodgers; Stacy Campbell-Bright; John P Kress; Shannon S Carson
Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation.
Critical care medicine 2008;36(3):706-14.
2008: Tahaniyat Lalani; Vivian H Chu; Chelsea A Grussemeyer; Shelby D Reed; Michael P Bolognesi; Joelle Y Friedman; ROBERT GRIFFITHS; David R Crosslin; Zeina A Kanafani; Keith Steven Kaye; G Ralph Corey; Vance G Fowler
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections.
Scandinavian journal of infectious diseases 2008;40(11-12):973-7.
2008: Shelby D Reed; Kevin J Anstrom; Yanhong Li; Kevin Schulman
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.
PharmacoEconomics 2008;26(5):435-46.
2008: Shelby D Reed; Katherine M Newton; Andrea Z LaCroix; Louis Grothaus; Verena S Grieco; Kelly Ehrlich
Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Menopause (New York, N.Y.) 2008;15(1):51-8.
2008: Shelby D Reed; Alisa M Shea; Kevin Schulman
Economic implications of potential changes to regulatory and reimbursement policies for medical devices.
Journal of general internal medicine 2008;23 Suppl 1():50-6.
2007: Alisa M Shea; Shelby D Reed; Lesley H Curtis; Michael Alexander; John J Villani; Kevin Schulman
Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003.
Neurosurgery 2007;61(6):1131-7; discussion 1137-8.
2007: David Whellan; Shelby D Reed; Lawrence Liao; Stuart D Gould; Christopher M O'connor; Kevin Schulman
Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives.
The American journal of cardiology 2007;99(2):256-60.
2006: Shelby D Reed; Robert M Califf; Kevin Schulman
How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Health affairs (Project Hope) 2006;25(5):1309-17.
2006: Frank M Torti; Shelby D Reed; Kevin Schulman
Analytic considerations in economic evaluations of multinational cardiovascular clinical trials.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2006;9(5):281-91.
2006: Shelby D Reed; john mcmurray; Eric J Velazquez; Kevin Schulman; Robert M Califf; Lars Kober; Aldo P Maggioni; Frans Van de Werf; Harvey D White; Rafael Diaz; Viatcheslav Mareev; Jan Murin
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Jula K Inrig; Shelby D Reed; Lynda A Szczech; John J Engemann; Joëlle Y Friedman; G Ralph Corey; Kevin Schulman; L Barth Reller; Vance G Fowler
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(3):518-24.
2006: Barbara D Alexander; Elizabeth Dodds Ashley; L Barth Reller; Shelby D Reed
Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.
Diagnostic microbiology and infectious disease 2006;54(4):277-82.
2006: Shelby D Reed; Jasmina I Radeva; Davey B Daniel; Samir H Mody; Jamie B Forlenza; R Scott McKenzie; Kevin Schulman
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
PharmacoEconomics 2006;24(5):479-94.
2005: Vivian H Chu; David R Crosslin; Joëlle Y Friedman; Shelby D Reed; Christopher H Cabell; ROBERT GRIFFITHS; Leah E Masselink; Keith Steven Kaye; G Ralph Corey; L Barth Reller; Martin E Stryjewski; Kevin Schulman; Vance G Fowler
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.
The American journal of medicine 2005;118(12):1416.
2005: Shelby D Reed; Jasmina I Radeva; Davey B Daniel; John M Fastenau; Denise Williams; Kevin Schulman
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia.
Current medical research and opinion 2005;21(10):1527-33.
2005: Shelby D Reed; Jasmina I Radeva; Kevin P Weinfurt; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Jennifer S Allsbrook; Leah E Masselink; Mary Ann Sellers; Robert M Califf; Kevin Schulman
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
American heart journal 2005;150(2):323-9.
2005: Jane Chang; Teresa L Kauf; Shibani Mahajan; Joanne M Jordan; Virginia B Kraus; Thomas P Vail; Shelby D Reed; Mohamed A Omar; Kristijan Kahler; Kevin Schulman
Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis.
Arthritis and rheumatism 2005;52(8):2366-75.
2005: John J Engemann; Joëlle Y Friedman; Shelby D Reed; ROBERT GRIFFITHS; Lynda A Szczech; Keith Steven Kaye; Martin E Stryjewski; L Barth Reller; Kevin Schulman; G Ralph Corey; Vance G Fowler
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(6):534-9.
2005: Shelby D Reed; Kevin J Anstrom; Ameet Bakhai; Andrew H Briggs; Robert M Califf; David J Cohen; Michael F Drummond; Henry A Glick; Ari Gnanasakthy; Mark A Hlatky; Bernie J O'Brien; Frank M Torti; Anastasios A Tsiatis; Andrew R Willan; Daniel B Mark; Kevin Schulman
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
American heart journal 2005;149(3):434-43.
2005: Shelby D Reed; Joëlle Y Friedman; John J Engemann; ROBERT GRIFFITHS; Kevin J Anstrom; Keith Steven Kaye; Martin E Stryjewski; Lynda A Szczech; L Barth Reller; G Ralph Corey; Kevin Schulman; Vance G Fowler
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(2):175-83.
2005: Shelby D Reed; Jasmina I Radeva; G Alastair Glendenning; Robert E Coleman; Kevin Schulman
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.
American journal of clinical oncology 2005;28(1):8-16.
2005: Jasmina I Radeva; Shelby D Reed; Zoltán Kaló; Teresa L Kauf; Edward Cantu; Nathalie Cretin; Kevin Schulman
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.
Clinical transplantation 2005;19(1):122-9.
2004: Mari M Kitahata; Shelby D Reed; Peter W Dillingham; Stephen E Van Rompaey; Alicia A Young; Robert D Harrington; King K Holmes
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death.
International journal of STD & AIDS 2004;15(12):803-10.
2004: Shelby D Reed; Kevin J Anstrom; Jennifer A Ludmer; G Alastair Glendenning; Kevin Schulman
Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Cancer 2004;101(11):2574-83.
2004: Kevin J Anstrom; Shelby D Reed; Andrew S Allen; G Alastair Glendenning; Kevin Schulman
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Cancer 2004;101(11):2584-92.
2004: Joëlle Y Friedman; Shelby D Reed; Kevin P Weinfurt; Kristijan Kahler; Emmanuel B Walter; Kevin Schulman
Parents' reported preference scores for childhood atopic dermatitis disease states.
BMC pediatrics 2004;4(1):21.
2004: Shelby D Reed; Joëlle Y Friedman; Eric J Velazquez; Ari Gnanasakthy; Robert M Califf; Kevin Schulman
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
American heart journal 2004;148(1):122-8.
2004: Frank M Torti; Lisa P Gwyther; Shelby D Reed; Joëlle Y Friedman; Kevin Schulman
A multinational review of recent trends and reports in dementia caregiver burden.
Alzheimer disease and associated disorders 2004;18(2):99-109.
2004: Shelby D Reed; Jasmina I Radeva; G Alastair Glendenning; Fred Saad; Kevin Schulman
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
The Journal of urology 2004;171(4):1537-42.
2004: Shelby D Reed; Todd A Lee; Douglas C McCrory
The economic burden of allergic rhinitis: a critical evaluation of the literature.
PharmacoEconomics 2004;22(6):345-61.
2003: Shelby D Reed; Peter W Dillingham; Andrew H Briggs; David L Veenstra; Sean D Sullivan
A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(3):252-64.
2003: Kevin Schulman; Edward A Stadtmauer; Shelby D Reed; H A Glick; Lee J Goldstein; J M Pines; J A Jackman; S Suzuki; Michael J Styler; Pamela Crilley; Thomas R Klumpp; Kenneth F Mangan; J H Glick
Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
Bone marrow transplantation 2003;31(3):205-10.
2003: Amy W Law; Shelby D Reed; John S Sundy; Kevin Schulman
Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.
The Journal of allergy and clinical immunology 2003;111(2):296-300.
2003: Bimal R Shah; Shelby D Reed; Jennifer Francis; David B Ridley; Kevin Schulman
The cost of inefficiency in US hospitals, 1985-1997.
Journal of health care finance 2003;30(1):1-9.
2003: Shelby D Reed; Joëlle Y Friedman; Ari Gnanasakthy; Kevin Schulman
Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial.
International journal of technology assessment in health care 2003;19(2):396-406.
2002: Jane E Onken; Joëlle Y Friedman; Subramanian Sujha; Kevin P Weinfurt; Shelby D Reed; Joshua H Malenbaum; Troy Schmidt; Kevin Schulman
Treatment patterns and costs associated with sessile colorectal polyps.
The American journal of gastroenterology 2002;97(11):2896-901.
2002: Shelby D Reed; Ramanan Laxminarayan; Douglas J Black; Sean D Sullivan
Economic issues and antibiotic resistance in the community.
The Annals of pharmacotherapy 2002;36(1):148-54.